- Home
- BDRX vs PHGE Comparison
BDRX vs PHGE Comparison
Compare BDRX & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BDRX | PHGE |
|---|---|---|
| Founded | 2000 | 2015 |
| Country | United Kingdom | United States |
| Employees | N/A | 20 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 2.0M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | BDRX | PHGE |
|---|---|---|
| Price | $1.32 | $0.18 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 37.1K | ★ 1.3M |
| Earning Date | 09-12-2025 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.60 | $0.17 |
| 52 Week High | $11.88 | $8.50 |
Technical Indicators
Market Signals| Indicator | BDRX | PHGE |
|---|---|---|
| Relative Strength Index (RSI) | 21.74 | 27.91 |
| Support Level | $1.04 | N/A |
| Resistance Level | $1.50 | $1.89 |
| Average True Range (ATR) | 0.21 | 0.02 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 33.97 | 24.79 |
Price Performance
Historical ComparisonAbout BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is a company focused on acquiring and further developing technologies that identify, track, and counter physical threats across defense, security, critical infrastructure, and first-response sectors. The Company's portfolio is built around the growing need for earlier and more accurate threat detection, particularly as UAVs and other autonomous systems play a larger role in defense and homeland security.